Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Alexion Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
Institute of Hematology and Blood Transfusion, Czech Republic
Children's Hospital of Philadelphia
Beth Israel Deaconess Medical Center
The First Affiliated Hospital of Soochow University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
The First Affiliated Hospital with Nanjing Medical University
Center for International Blood and Marrow Transplant Research
National Cancer Institute (NCI)
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Boston Children's Hospital
University of Oxford
Taiho Oncology, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Changhai Hospital
University Hospital, Brest
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Takeda
Disc Medicine, Inc
Zhejiang Cancer Hospital
The First Hospital of Jilin University
Ossium Health, Inc.
Mayo Clinic
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Centre Hospitalier Universitaire de Nice
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
University of Vermont
Apollo Therapeutics Ltd
Quercis Pharma AG
Wake Forest University Health Sciences
University of Vermont Medical Center
First Affiliated Hospital of Zhejiang University
Institut Pasteur du Cambodge